Infliximab Concentrations in Participants with Moderate to Severe COVID-19

J Clin Pharmacol. 2023 Nov 30. doi: 10.1002/jcph.2388. Online ahead of print.NO ABSTRACTPMID:38031826 | DOI:10.1002/jcph.2388

Source: The Journal of Clinical Pharmacology - November 30, 2023 Category: Drugs & Pharmacology Authors: Stephen J Balevic Dima Dandachi Danielle Dixon Richard M W Hoetelmans Sam Bozzette Matthew W McCarthy ACTIV-1 Study Team Source Type: research